IP Library Granted Patent US 8,562,588
Granted Patent B2
US 8,562,588 · App. 13/556,510 · Granted Oct 22, 2013

Irreversible electroporation and tissue regeneration

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,562,588
App. No.
13/556,510
Granted
Oct 22, 2013
Kind
B2
Abstract

A method and device are herein described to treat a target region of tissue, using at least one energy delivery device coupled to a power source and positioned in a treatment position so as to irreversibly electroporate tissue to ablate a target region, and introduce regenerative materials into a treated region.

Claims (32)

1. A method of treating a target region of tissue in a living mammal by electrical ablation comprising:

positioning in the target region a shaft comprising at least one electrode integral to the shaft, and at least one lumen adapted to receive at least one regenerative material;

applying a plurality of electrical pulses through the electrode in an amount sufficient to induce cell death by irreversible electroporation in the target region;

introducing through the shaft lumen the at least one regenerative material to the target region after the step of applying a plurality of electrical pulses.

2. The method of claim 1 , further comprising, after the step of introducing, withdrawing the shaft while ablating tissue cells around the shaft.

3. The method of claim 2 , wherein the step of withdrawing includes generating thermal energy around the shaft using radio frequency ablation.

4. The method of claim 1 , wherein the step of positioning includes inserting the shaft into a tubular body part.

5. The method of claim 4 , wherein the step of inserting the shaft includes inserting the shaft into a blood vessel.

6. The method of claim 1 , prior to the step of introducing the at least one regenerative material, further comprising releasing at least one factor to the target region.

7. The method of claim 6 , wherein the step of releasing includes releasing as a factor at least one of water, ions, hormones, paracrine agents, pharmacological mediators and vasoreactive elements.

8. The method of claim 1 , wherein the step of introducing the at least one regenerative material includes using a programmable infusion pump to insert a pre-programmed amount of the regenerative material into the target region of tissue.

9. The method of claim 1 , further comprising using a temperature controller to maintain the temperature of the regenerative material contained in a container at a selected temperature.

10. The method of claim 1 , wherein the step of positioning includes positioning the shaft in one of digestive, skeletal, muscular, nervous, endocrine, circulatory, reproductive, integumentary, lymphatic, urinary, and soft tissue.

11. The method of claim 1 , wherein the step of introducing includes introducing, as the regenerative material, at least one of totipotent, pluripotent, multipotent, and unipotent cells.

12. The method of claim 1 , wherein the step of introducing includes introducing the regenerative material that is at least one of autogeneic, isogeneic, allogeneic, and xenogeneic.

13. The method of claim 1 , wherein the step of introducing includes introducing, as the regenerative material, at least one of smooth muscle cells, epithelial cells, endothelial cells, adult stem cells, vascular endothelial cell precursor cells, and mesodermal stromal cells.

14. The method of claim 1 , wherein the step of introducing includes introducing, as the regenerative material, cells that are the same cell type as the primary cell type of the target region.

15. The method of claim 1 , wherein the step of introducing includes introducing, as the regenerative material, one of liver cells, lung cells, pancreas cells, and bone cells.

16. The method of claim 1 , wherein the step of introducing includes introducing, as the regenerative material, growth factors.

17. The method of claim 1 , wherein the step of introducing includes introducing, as the regenerative material, a molecule from at least one of DNA, RNA, proteins, carbohydrates, sugars, lipids, enzymes, proteases, and steroids.

18. The method of claim 1 , wherein the step of introducing includes introducing, as the regenerative material, at least one of polysaccharides, proteoglycans, hyaluronic acid, collagen, fibronectin, elastin, laminin, and integrins.

19. A method of treating a target region of tissue in a living mammal by irreversible electroporation comprising:

positioning in the target region a shaft comprising at least one electrode integral to the shaft and at least one lumen adapted to receive at least one regenerative material;

applying a plurality of electrical pulses through the electrode in an amount sufficient to induce irreversible electroporation of tissue cells in the target region;

introducing through the shaft lumen the at least one regenerative material to the target region after the step of applying a plurality of electrical pulses.

20. The method of claim 19 , further comprising, after the step of introducing, withdrawing the shaft while ablating tissue cells around the shaft.

21. The method of claim 19 , wherein the step of withdrawing includes generating thermal energy around the shaft using radio frequency ablation.

22. The method of claim 19 , wherein the step of positioning includes inserting the shaft into a tubular body part.

23. The method of claim 22 , wherein the step of inserting the shaft includes inserting the shaft into a blood vessel.

24. The method of claim 19 , wherein the step of introducing the at least one regenerative material includes using a programmable infusion pump to insert a pre-programmed amount of the regenerative material into the target region of tissue.

25. The method of claim 19 , further comprising using a temperature controller to maintain the temperature of the regenerative material contained in a container at a selected temperature.

26. The method of claim 19 , wherein the step of introducing the at least one regenerative material includes introducing a molecule from at least one of DNA, RNA, proteins, carbohydrates, sugars, lipids, enzymes, proteases, and steroids.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Jun 8, 2023
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ANGIODYNAMICS, INC.
Reel/Frame 063940/0362 →
SECURITY INTEREST Recorded Aug 31, 2022
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 061360/0668 →
RELEASE OF SECURITY INTEREST Recorded Aug 31, 2022
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ANGIODYNAMICS, INC.
Reel/Frame 061363/0446 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Jun 5, 2019
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 049371/0657 →
RELEASE OF SECURITY INTEREST Recorded Nov 14, 2016
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ANGIODYNAMICS, INC.
Reel/Frame 040688/0540 →
SECURITY INTEREST Recorded Nov 8, 2016
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 040613/0049 →
SECURITY AGREEMENT Recorded Sep 30, 2013
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 031315/0720 →